285 related articles for article (PubMed ID: 30646926)
1. Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms.
Wiffin M; Smith L; Antonio J; Johnstone J; Beasley L; Roberts J
J Int Soc Sports Nutr; 2019 Jan; 16(1):1. PubMed ID: 30646926
[TBL] [Abstract][Full Text] [Related]
2. Case Study: Utilizing a Low FODMAP Diet to Combat Exercise-Induced Gastrointestinal Symptoms.
Lis D; Ahuja KD; Stellingwerff T; Kitic CM; Fell J
Int J Sport Nutr Exerc Metab; 2016 Oct; 26(5):481-487. PubMed ID: 27097380
[TBL] [Abstract][Full Text] [Related]
3. Low FODMAP: A Preliminary Strategy to Reduce Gastrointestinal Distress in Athletes.
Lis DM; Stellingwerff T; Kitic CM; Fell JW; Ahuja KDK
Med Sci Sports Exerc; 2018 Jan; 50(1):116-123. PubMed ID: 28891824
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
Erickson J; Korczak R; Wang Q; Slavin J
Nutr J; 2017 May; 16(1):35. PubMed ID: 28545589
[TBL] [Abstract][Full Text] [Related]
5. Impact of 24-h high and low fermentable oligo-, di-, monosaccharide, and polyol diets on markers of exercise-induced gastrointestinal syndrome in response to exertional heat stress.
Gaskell SK; Taylor B; Muir J; Costa RJS
Appl Physiol Nutr Metab; 2020 Jun; 45(6):569-580. PubMed ID: 31652404
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Nutrition Strategies Employed by Ultra-Endurance Athletes to Alleviate Exercise-Induced Gastrointestinal Symptoms-A Systematic Review.
Ryan T; Daly E; Ryan L
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892406
[TBL] [Abstract][Full Text] [Related]
7. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
8. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
Algera JP; Demir D; Törnblom H; Nybacka S; Simrén M; Störsrud S
Clin Nutr; 2022 Dec; 41(12):2792-2800. PubMed ID: 36384081
[TBL] [Abstract][Full Text] [Related]
9. High Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Consumption Among Endurance Athletes and Relationship to Gastrointestinal Symptoms.
Killian LA; Muir JG; Barrett JS; Burd NA; Lee SY
Front Nutr; 2021; 8():637160. PubMed ID: 33959628
[TBL] [Abstract][Full Text] [Related]
10. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial.
Goyal O; Batta S; Nohria S; Kishore H; Goyal P; Sehgal R; Sood A
J Gastroenterol Hepatol; 2021 Aug; 36(8):2107-2115. PubMed ID: 33464683
[TBL] [Abstract][Full Text] [Related]
11. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
Zahedi MJ; Behrouz V; Azimi M
J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
[TBL] [Abstract][Full Text] [Related]
12. Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review.
Fisher K; Hutcheon D; Ziegler J
Nutr Clin Pract; 2020 Apr; 35(2):231-245. PubMed ID: 30937981
[TBL] [Abstract][Full Text] [Related]
13. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.
Varjú P; Farkas N; Hegyi P; Garami A; Szabó I; Illés A; Solymár M; Vincze Á; Balaskó M; Pár G; Bajor J; Szűcs Á; Huszár O; Pécsi D; Czimmer J
PLoS One; 2017; 12(8):e0182942. PubMed ID: 28806407
[TBL] [Abstract][Full Text] [Related]
14. A low fermentable oligo-di-mono saccharides and polyols (FODMAP) diet reduced pain and improved daily life in fibromyalgia patients.
Marum AP; Moreira C; Saraiva F; Tomas-Carus P; Sousa-Guerreiro C
Scand J Pain; 2016 Oct; 13():166-172. PubMed ID: 28850525
[TBL] [Abstract][Full Text] [Related]
15. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.
Valeur J; Småstuen MC; Knudsen T; Lied GA; Røseth AG
Dig Dis Sci; 2018 Feb; 63(2):429-436. PubMed ID: 29302878
[TBL] [Abstract][Full Text] [Related]
16. The impact of 48 h high carbohydrate diets with high and low FODMAP content on gastrointestinal status and symptoms in response to endurance exercise, and subsequent endurance performance.
Scrivin R; Slater G; Mika A; Rauch C; Young P; Martinez I; Costa RJS
Appl Physiol Nutr Metab; 2024 Jun; 49(6):773-791. PubMed ID: 38359412
[TBL] [Abstract][Full Text] [Related]
17. Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study.
Kortlever TL; Ten Bokkel Huinink S; Offereins M; Hebblethwaite C; O'Brien L; Leeper J; Mulder CJJ; Barrett JS; Gearry RB
Nutr Clin Pract; 2019 Aug; 34(4):623-630. PubMed ID: 30644587
[TBL] [Abstract][Full Text] [Related]
18. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
[TBL] [Abstract][Full Text] [Related]
19. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.
Laatikainen R; Koskenpato J; Hongisto SM; Loponen J; Poussa T; Hillilä M; Korpela R
Aliment Pharmacol Ther; 2016 Sep; 44(5):460-70. PubMed ID: 27417338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
